How is cerebral arteriosclerosis diagnosed?

Aug 02, 2022 Source: Cainiu Health
Dr. Li Man
Introduction
The primary diagnostic approaches for cerebral arteriosclerosis include assessment of associated risk factors, blood tests, and imaging studies. Assessment of associated risk factors involves monitoring blood pressure, blood glucose levels, and lipid profiles. Blood tests are used to monitor blood glucose, lipids, cholesterol, serum uric acid, and homocysteine—helping to identify and mitigate risk factors for cerebral arteriosclerosis. Imaging studies include carotid color Doppler ultrasound.

  Cerebral arteriosclerosis is a common chronic degenerative disease among middle-aged and elderly individuals. It predisposes patients to complications such as stroke and dementia. Therefore, early attention should be paid to symptoms like dizziness and memory loss. Early detection and timely treatment are crucial for disease management and recovery. So, how is cerebral arteriosclerosis diagnosed?

  How Is Cerebral Arteriosclerosis Diagnosed?

  Diagnosis of cerebral arteriosclerosis primarily involves assessment of associated risk factors, blood tests, and imaging studies. Risk factor evaluation includes monitoring blood pressure, blood glucose, and lipid levels. Blood tests assess fasting glucose, lipid profile (including cholesterol), serum uric acid, and homocysteine levels—helping identify and mitigate key contributors to cerebral arteriosclerosis. Imaging modalities include carotid color Doppler ultrasound, brain magnetic resonance imaging (MRI), CT angiography (CTA) of the head and neck, and whole-brain digital subtraction angiography (DSA). Carotid color Doppler ultrasound is the most convenient and widely used initial screening tool, enabling visualization of carotid artery stenosis and plaque formation. Clinically, brain MRI demonstrates approximately 60–80% accuracy in diagnosing cerebral arteriosclerosis.

  Management of cerebral arteriosclerosis encompasses both general lifestyle interventions and medical therapy. For modifiable risk factors, standard approaches include smoking cessation, blood pressure control, glycemic management, and lipid-lowering therapy. Medical treatment may involve further diagnostic evaluation when indicated, with the goals of preventing progression of arterial hardening and reducing the risk of new or worsening cerebral infarction. This includes pharmacologic strategies to improve cerebral circulation and provide neuroprotective effects.

  Patients are advised to maintain a light, low-fat diet and engage in regular physical exercise to enhance overall physical fitness. We hope this information proves helpful.